Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/19/2014 | WO2014049447A3 A whole, leech saliva extract |
06/19/2014 | WO2014047477A3 Multilayer biodegradable microparticles for sustained release of therapeutic agents |
06/19/2014 | WO2014044794A3 Pharmaceutical composition |
06/19/2014 | WO2013177147A3 Copolymer-xerogel nanocomposites useful for drug delivery |
06/19/2014 | WO2013158814A8 Immediate release, abuse deterrent pharmaceutical compositions |
06/19/2014 | US20140171515 Compositions and methods for transmucosal absorption |
06/19/2014 | US20140171509 Non-Aqueous Patch |
06/19/2014 | US20140171508 Method of treating parkinson's disease comprising administering deferoxamine (dfo) to the upper one-third of the nasal cavity |
06/19/2014 | US20140171490 Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients |
06/19/2014 | US20140171460 Methods and compositions for treatment of epithelial wounds |
06/19/2014 | US20140171457 Implantable Polymeric Device for Sustained Release of Buprenorphine |
06/19/2014 | US20140171441 Pharmaceutical compositions with enhanced performance |
06/19/2014 | US20140171401 Novel pharmaceutical formulation of cefixime for enhanced bioavailability |
06/19/2014 | US20140171399 Topical skin care composition |
06/19/2014 | US20140171398 Formoterol/steroid bronchodilating compositions and methods of use thereof |
06/19/2014 | US20140171383 Central administration of stable formulations of therapeutic agents for cns conditions |
06/19/2014 | US20140171364 Stable glucagon formulations for the treatment of hypoglycemia |
06/19/2014 | US20140171358 Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereof |
06/19/2014 | US20140170299 Method of making coated microstructures |
06/19/2014 | US20140170228 Combination therapy methods for treating proliferative diseases |
06/19/2014 | US20140170227 Method for Making Nanolipidic Particles |
06/19/2014 | US20140170226 Method for Making Nanolipidic Particles |
06/19/2014 | US20140170225 Immunotherapy for treatment of amyloid-related disorders using encapsulated beta-amyloid peptides |
06/19/2014 | US20140170224 Gelatin-based microgels |
06/19/2014 | US20140170222 Xanthophyll compositions and methods of use |
06/19/2014 | US20140170220 Multimodal particulate formulations |
06/19/2014 | US20140170219 Composition and method for treating hpv |
06/19/2014 | US20140170218 Compositions containing broccoli seeds for treatment or preventing prostate cancer |
06/19/2014 | US20140170217 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
06/19/2014 | US20140170216 Bupropion hydrobromide polymorphs |
06/19/2014 | US20140170215 Orally disintegrating tablets and methods of manufacture |
06/19/2014 | US20140170214 Supramolecular capsules |
06/19/2014 | US20140170213 Capsule formulation comprising montelukast and levocetirizine |
06/19/2014 | US20140170212 Stable digestive enzyme compositions |
06/19/2014 | US20140170209 Pharmaceutical invention of tapentadol |
06/19/2014 | US20140170208 Transdermal patch formulation |
06/19/2014 | US20140170206 Composition for the transdermal delivery of fentanyl |
06/19/2014 | US20140170205 Ropinirole-containing patch and package thereof |
06/19/2014 | US20140170204 Multilayer Thin Film Drug Delivery Device and Methods of Making and Using the Same |
06/19/2014 | US20140170196 Feminine anti-itch cloth |
06/19/2014 | US20140170195 Anhydrous Powder-to-Liquid Particles |
06/19/2014 | US20140170081 Pharmaceutical aerosol product for administration by oral or nasal inhalation |
06/19/2014 | US20140170079 Abuse-proofed dosage form |
06/19/2014 | US20140167307 Chemical compositions for delivery of pharmaceutical agents |
06/18/2014 | EP2743343A1 Spray formulation of mesenchymal stem cells for the treatment of chronic wounds |
06/18/2014 | EP2743277A1 Highly functional cellulose composite |
06/18/2014 | EP2743265A1 Improved amino lipids and methods for the delivery of nucleic acids |
06/18/2014 | EP2742954A1 "Silymarin aqueous formulation" |
06/18/2014 | EP2742943A1 Composition containing s-adenosyl-l-methionine with excellent storage stability |
06/18/2014 | EP2742941A1 Pharmaceutical composition containing diamine derivative |
06/18/2014 | EP2742940A1 Salts of aza-bicyclo-di-aryl ethers for adminstration once daily, twice daily or thrice daily |
06/18/2014 | EP2742934A1 Amorphous rotigotine transdermal system |
06/18/2014 | EP2742932A1 Gel compositions |
06/18/2014 | EP2742931A1 Topical drug for treating ulcers |
06/18/2014 | EP2742070A1 Degradation-resistant cross-linked, low-molecular-weight hyaluronate |
06/18/2014 | EP2741775A1 Polymeric nanoparticles for photosensitizers |
06/18/2014 | EP2741765A1 Injectable solution of at least one type of basal insulin |
06/18/2014 | EP2741754A1 Use of a polysaccharide polymer from the seeds of the tamarind tree in protecting against tobacco-associated damages |
06/18/2014 | EP2741751A2 Concentrated felbamate formulations for parenteral administration |
06/18/2014 | EP2741750A1 Pharmaceutical composition comprising cefuroxime |
06/18/2014 | EP2741740A1 Vacuum -assisted preservation of biological products, in particular of vaccines |
06/18/2014 | EP2741739A2 Pharmaceutical compositions |
06/18/2014 | EP2741738A1 Sustained release composition of prostacyclin |
06/18/2014 | EP2741737A1 Orodispersible films for the manufacturing of individualised medicine or for large scale production |
06/18/2014 | EP2741736A1 Taste masked pharmaceutical composition |
06/18/2014 | EP2741735A1 Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
06/18/2014 | EP2741734A1 Method for producing and monitoring oral active ingredient films |
06/18/2014 | EP2741733A1 Antioxidant topical compositions |
06/18/2014 | EP2741730A1 Multiple emulsion |
06/18/2014 | DE102012023343A1 Layer structure, useful for delivering active ingredient e.g. drug to outside, comprises carrier substrate, areas containing active ingredient, and semipermeable outer layer applied on non-drug occupied intermediate areas on substrate |
06/18/2014 | DE102006007482B4 Vorrichtung und Verfahren zur Herstellung einer rohrförmigen Umhüllung Apparatus and method for preparing a tubular sheathing |
06/18/2014 | CN203651110U 聚氨酯复合无纺布和膏贴 Polyurethane composite nonwovens and Plaster |
06/18/2014 | CN203647738U 一种医用高压氧晶体液的制备装置 A medical preparation device hyperbaric oxygen liquid crystal |
06/18/2014 | CN1899276B Composition of rheinic acid or rheinic acid compounds use in preparing medicine for preventing intestinal adhesion |
06/18/2014 | CN103874727A Injection-molded dosage form |
06/18/2014 | CN103874722A Method for manufacturing block copolymer |
06/18/2014 | CN103874511A Brain tumor targeting peptides and methods |
06/18/2014 | CN103874497A Composition for the treatment of fistula |
06/18/2014 | CN103874490A Combinations of corroles and statins |
06/18/2014 | CN103874489A Compositions comprising salbutamol sulphate |
06/18/2014 | CN103874485A Formulations and dosage forms of oxidized phospholipids |
06/18/2014 | CN103874484A Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin |
06/18/2014 | CN103874483A Crystalline microparticles of a beta-agonist coated with a fatty acid |
06/18/2014 | CN103874482A Liposome composite body |
06/18/2014 | CN103874481A Methods and apparatus for delivering a therapeutic agent to nasopharyngeal mucosa targets |
06/18/2014 | CN103874480A Sustained release composition of prostacyclin |
06/18/2014 | CN103874422A Novel coating system |
06/18/2014 | CN103864751A Gatifloxacin lactate and preparation method thereof |
06/18/2014 | CN103864628A Ambroxol hydrochloride compound and orally disintegrating tablet |
06/18/2014 | CN103861123A Diagnosis-treatment integrated nanometer material, diagnosis-treatment integrated nanometer preparation and preparation method of nanometer preparation |
06/18/2014 | CN103861117A Pravastatin sodium dispersible tablets and preparation method thereof |
06/18/2014 | CN103861115A Hemoglobin nano-particle and preparation method thereof |
06/18/2014 | CN103861114A Functional vegetated substrate hollow capsule |
06/18/2014 | CN103861113A Paclitaxel antitumor preparation and preparation method thereof |
06/18/2014 | CN103861112A Pharmaceutical composition based on polymer nanoparticle carrier and preparation method thereof |
06/18/2014 | CN103861111A Tamper resistant oral pharmaceutical dosage forms comprising opioid analgesic |
06/18/2014 | CN103861105A Compound preparation comprising traditional Chinese medicine pseudo-ginseng and lipid-lowering drug statins and its preparation method |
06/18/2014 | CN103861103A Nano particles compounded of up-conversion nano particles and gold nanorods and preparation method and application of nano particles |
06/18/2014 | CN103861091A Medicine composition for treating urocystitis |
06/18/2014 | CN103861089A Derivative of GLP-1 analogues or pharmaceutical salt injection of derivative as well as preparation method and applications of derivative of GLP-1 analogues or pharmaceutical salt injection of derivative |